The Interplay between Inflammation, Anti-Angiogenic Agents, and Immune Checkpoint Inhibitors: Perspectives for Renal Cell Cancer Treatment
暂无分享,去创建一个
V. Conteduca | U. de Giorgi | G. Schepisi | G. Gurioli | C. Lolli | V. Gallá | A. Farolfi | C. Casadei | N. Brighi | S. Gargiulo